[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2023-2029

February 2023 | 115 pages | ID: G4A704F5135EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.

LPI (LP Information)' newest research report, the “Drugs For Herpes Labialis (Oral Herpes) Industry Forecast” looks at past sales and reviews total world Drugs For Herpes Labialis (Oral Herpes) sales in 2022, providing a comprehensive analysis by region and market sector of projected Drugs For Herpes Labialis (Oral Herpes) sales for 2023 through 2029. With Drugs For Herpes Labialis (Oral Herpes) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs For Herpes Labialis (Oral Herpes) industry.

This Insight Report provides a comprehensive analysis of the global Drugs For Herpes Labialis (Oral Herpes) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs For Herpes Labialis (Oral Herpes) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drugs For Herpes Labialis (Oral Herpes) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs For Herpes Labialis (Oral Herpes) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs For Herpes Labialis (Oral Herpes).

The global Drugs For Herpes Labialis (Oral Herpes) market size is projected to grow from US$ 2404.5 million in 2022 to US$ 3064.8 million in 2029; it is expected to grow at a CAGR of 3064.8 from 2023 to 2029.

Global Drugs for Herpes Labialis (Oral Herpes) key players include GSK, Novartis, Teva, Mylan, Cadila, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 35%, followed by Europe, with a share about 30 percent. In terms of product, Rx Drugs is the largest segment, with a share about 90%. And in terms of application, the largest application is Oral, followed by External Use, and Injection, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs For Herpes Labialis (Oral Herpes) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Valacyclovir
  • Aciclovir
  • Famciclovir
  • Docosanol
  • Other
Segmentation by application
  • Tablets
  • Capsules
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GSK
  • Novartis
  • Teva
  • Mylan
  • Cadila
  • Apotex
  • Medivir
  • Livzon
  • Luoxin
  • Med shine
  • Bayer (Campho Phenique)
  • Blistex
  • Kelun Group
  • Hikma
  • Haiwang
  • Carmex
  • Cipher
Key Questions Addressed in this Report

What is the 10-year outlook for the global Drugs For Herpes Labialis (Oral Herpes) market?

What factors are driving Drugs For Herpes Labialis (Oral Herpes) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Drugs For Herpes Labialis (Oral Herpes) market opportunities vary by end market size?

How does Drugs For Herpes Labialis (Oral Herpes) break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs For Herpes Labialis (Oral Herpes) Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Drugs For Herpes Labialis (Oral Herpes) by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Drugs For Herpes Labialis (Oral Herpes) by Country/Region, 2018, 2022 & 2029
2.2 Drugs For Herpes Labialis (Oral Herpes) Segment by Type
  2.2.1 Valacyclovir
  2.2.2 Aciclovir
  2.2.3 Famciclovir
  2.2.4 Docosanol
  2.2.5 Other
2.3 Drugs For Herpes Labialis (Oral Herpes) Sales by Type
  2.3.1 Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Type (2018-2023)
  2.3.2 Global Drugs For Herpes Labialis (Oral Herpes) Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Drugs For Herpes Labialis (Oral Herpes) Sale Price by Type (2018-2023)
2.4 Drugs For Herpes Labialis (Oral Herpes) Segment by Application
  2.4.1 Tablets
  2.4.2 Capsules
2.5 Drugs For Herpes Labialis (Oral Herpes) Sales by Application
  2.5.1 Global Drugs For Herpes Labialis (Oral Herpes) Sale Market Share by Application (2018-2023)
  2.5.2 Global Drugs For Herpes Labialis (Oral Herpes) Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Drugs For Herpes Labialis (Oral Herpes) Sale Price by Application (2018-2023)

3 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COMPANY

3.1 Global Drugs For Herpes Labialis (Oral Herpes) Breakdown Data by Company
  3.1.1 Global Drugs For Herpes Labialis (Oral Herpes) Annual Sales by Company (2018-2023)
  3.1.2 Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Company (2018-2023)
3.2 Global Drugs For Herpes Labialis (Oral Herpes) Annual Revenue by Company (2018-2023)
  3.2.1 Global Drugs For Herpes Labialis (Oral Herpes) Revenue by Company (2018-2023)
  3.2.2 Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2018-2023)
3.3 Global Drugs For Herpes Labialis (Oral Herpes) Sale Price by Company
3.4 Key Manufacturers Drugs For Herpes Labialis (Oral Herpes) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Drugs For Herpes Labialis (Oral Herpes) Product Location Distribution
  3.4.2 Players Drugs For Herpes Labialis (Oral Herpes) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY GEOGRAPHIC REGION

4.1 World Historic Drugs For Herpes Labialis (Oral Herpes) Market Size by Geographic Region (2018-2023)
  4.1.1 Global Drugs For Herpes Labialis (Oral Herpes) Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Drugs For Herpes Labialis (Oral Herpes) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drugs For Herpes Labialis (Oral Herpes) Market Size by Country/Region (2018-2023)
  4.2.1 Global Drugs For Herpes Labialis (Oral Herpes) Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Drugs For Herpes Labialis (Oral Herpes) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drugs For Herpes Labialis (Oral Herpes) Sales Growth
4.4 APAC Drugs For Herpes Labialis (Oral Herpes) Sales Growth
4.5 Europe Drugs For Herpes Labialis (Oral Herpes) Sales Growth
4.6 Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales Growth

5 AMERICAS

5.1 Americas Drugs For Herpes Labialis (Oral Herpes) Sales by Country
  5.1.1 Americas Drugs For Herpes Labialis (Oral Herpes) Sales by Country (2018-2023)
  5.1.2 Americas Drugs For Herpes Labialis (Oral Herpes) Revenue by Country (2018-2023)
5.2 Americas Drugs For Herpes Labialis (Oral Herpes) Sales by Type
5.3 Americas Drugs For Herpes Labialis (Oral Herpes) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drugs For Herpes Labialis (Oral Herpes) Sales by Region
  6.1.1 APAC Drugs For Herpes Labialis (Oral Herpes) Sales by Region (2018-2023)
  6.1.2 APAC Drugs For Herpes Labialis (Oral Herpes) Revenue by Region (2018-2023)
6.2 APAC Drugs For Herpes Labialis (Oral Herpes) Sales by Type
6.3 APAC Drugs For Herpes Labialis (Oral Herpes) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Drugs For Herpes Labialis (Oral Herpes) by Country
  7.1.1 Europe Drugs For Herpes Labialis (Oral Herpes) Sales by Country (2018-2023)
  7.1.2 Europe Drugs For Herpes Labialis (Oral Herpes) Revenue by Country (2018-2023)
7.2 Europe Drugs For Herpes Labialis (Oral Herpes) Sales by Type
7.3 Europe Drugs For Herpes Labialis (Oral Herpes) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) by Country
  8.1.1 Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Revenue by Country (2018-2023)
8.2 Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales by Type
8.3 Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs For Herpes Labialis (Oral Herpes)
10.3 Manufacturing Process Analysis of Drugs For Herpes Labialis (Oral Herpes)
10.4 Industry Chain Structure of Drugs For Herpes Labialis (Oral Herpes)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Drugs For Herpes Labialis (Oral Herpes) Distributors
11.3 Drugs For Herpes Labialis (Oral Herpes) Customer

12 WORLD FORECAST REVIEW FOR DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY GEOGRAPHIC REGION

12.1 Global Drugs For Herpes Labialis (Oral Herpes) Market Size Forecast by Region
  12.1.1 Global Drugs For Herpes Labialis (Oral Herpes) Forecast by Region (2024-2029)
  12.1.2 Global Drugs For Herpes Labialis (Oral Herpes) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drugs For Herpes Labialis (Oral Herpes) Forecast by Type
12.7 Global Drugs For Herpes Labialis (Oral Herpes) Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 GSK
  13.1.1 GSK Company Information
  13.1.2 GSK Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.1.3 GSK Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 GSK Main Business Overview
  13.1.5 GSK Latest Developments
13.2 Novartis
  13.2.1 Novartis Company Information
  13.2.2 Novartis Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.2.3 Novartis Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Novartis Main Business Overview
  13.2.5 Novartis Latest Developments
13.3 Teva
  13.3.1 Teva Company Information
  13.3.2 Teva Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.3.3 Teva Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Teva Main Business Overview
  13.3.5 Teva Latest Developments
13.4 Mylan
  13.4.1 Mylan Company Information
  13.4.2 Mylan Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.4.3 Mylan Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Mylan Main Business Overview
  13.4.5 Mylan Latest Developments
13.5 Cadila
  13.5.1 Cadila Company Information
  13.5.2 Cadila Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.5.3 Cadila Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Cadila Main Business Overview
  13.5.5 Cadila Latest Developments
13.6 Apotex
  13.6.1 Apotex Company Information
  13.6.2 Apotex Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.6.3 Apotex Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Apotex Main Business Overview
  13.6.5 Apotex Latest Developments
13.7 Medivir
  13.7.1 Medivir Company Information
  13.7.2 Medivir Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.7.3 Medivir Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Medivir Main Business Overview
  13.7.5 Medivir Latest Developments
13.8 Livzon
  13.8.1 Livzon Company Information
  13.8.2 Livzon Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.8.3 Livzon Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Livzon Main Business Overview
  13.8.5 Livzon Latest Developments
13.9 Luoxin
  13.9.1 Luoxin Company Information
  13.9.2 Luoxin Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.9.3 Luoxin Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Luoxin Main Business Overview
  13.9.5 Luoxin Latest Developments
13.10 Med shine
  13.10.1 Med shine Company Information
  13.10.2 Med shine Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.10.3 Med shine Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Med shine Main Business Overview
  13.10.5 Med shine Latest Developments
13.11 Bayer (Campho Phenique)
  13.11.1 Bayer (Campho Phenique) Company Information
  13.11.2 Bayer (Campho Phenique) Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.11.3 Bayer (Campho Phenique) Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Bayer (Campho Phenique) Main Business Overview
  13.11.5 Bayer (Campho Phenique) Latest Developments
13.12 Blistex
  13.12.1 Blistex Company Information
  13.12.2 Blistex Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.12.3 Blistex Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Blistex Main Business Overview
  13.12.5 Blistex Latest Developments
13.13 Kelun Group
  13.13.1 Kelun Group Company Information
  13.13.2 Kelun Group Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.13.3 Kelun Group Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Kelun Group Main Business Overview
  13.13.5 Kelun Group Latest Developments
13.14 Hikma
  13.14.1 Hikma Company Information
  13.14.2 Hikma Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.14.3 Hikma Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Hikma Main Business Overview
  13.14.5 Hikma Latest Developments
13.15 Haiwang
  13.15.1 Haiwang Company Information
  13.15.2 Haiwang Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.15.3 Haiwang Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Haiwang Main Business Overview
  13.15.5 Haiwang Latest Developments
13.16 Carmex
  13.16.1 Carmex Company Information
  13.16.2 Carmex Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.16.3 Carmex Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Carmex Main Business Overview
  13.16.5 Carmex Latest Developments
13.17 Cipher
  13.17.1 Cipher Company Information
  13.17.2 Cipher Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
  13.17.3 Cipher Drugs For Herpes Labialis (Oral Herpes) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Cipher Main Business Overview
  13.17.5 Cipher Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Drugs For Herpes Labialis (Oral Herpes) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drugs For Herpes Labialis (Oral Herpes) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Valacyclovir
Table 4. Major Players of Aciclovir
Table 5. Major Players of Famciclovir
Table 6. Major Players of Docosanol
Table 7. Major Players of Other
Table 8. Global Drugs For Herpes Labialis (Oral Herpes) Sales by Type (2018-2023) & (K Units)
Table 9. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Type (2018-2023)
Table 10. Global Drugs For Herpes Labialis (Oral Herpes) Revenue by Type (2018-2023) & ($ million)
Table 11. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2018-2023)
Table 12. Global Drugs For Herpes Labialis (Oral Herpes) Sale Price by Type (2018-2023) & (USD/Unit)
Table 13. Global Drugs For Herpes Labialis (Oral Herpes) Sales by Application (2018-2023) & (K Units)
Table 14. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Application (2018-2023)
Table 15. Global Drugs For Herpes Labialis (Oral Herpes) Revenue by Application (2018-2023)
Table 16. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2018-2023)
Table 17. Global Drugs For Herpes Labialis (Oral Herpes) Sale Price by Application (2018-2023) & (USD/Unit)
Table 18. Global Drugs For Herpes Labialis (Oral Herpes) Sales by Company (2018-2023) & (K Units)
Table 19. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Company (2018-2023)
Table 20. Global Drugs For Herpes Labialis (Oral Herpes) Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2018-2023)
Table 22. Global Drugs For Herpes Labialis (Oral Herpes) Sale Price by Company (2018-2023) & (USD/Unit)
Table 23. Key Manufacturers Drugs For Herpes Labialis (Oral Herpes) Producing Area Distribution and Sales Area
Table 24. Players Drugs For Herpes Labialis (Oral Herpes) Products Offered
Table 25. Drugs For Herpes Labialis (Oral Herpes) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Drugs For Herpes Labialis (Oral Herpes) Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share Geographic Region (2018-2023)
Table 30. Global Drugs For Herpes Labialis (Oral Herpes) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Drugs For Herpes Labialis (Oral Herpes) Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Country/Region (2018-2023)
Table 34. Global Drugs For Herpes Labialis (Oral Herpes) Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Drugs For Herpes Labialis (Oral Herpes) Sales by Country (2018-2023) & (K Units)
Table 37. Americas Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Country (2018-2023)
Table 38. Americas Drugs For Herpes Labialis (Oral Herpes) Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Country (2018-2023)
Table 40. Americas Drugs For Herpes Labialis (Oral Herpes) Sales by Type (2018-2023) & (K Units)
Table 41. Americas Drugs For Herpes Labialis (Oral Herpes) Sales by Application (2018-2023) & (K Units)
Table 42. APAC Drugs For Herpes Labialis (Oral Herpes) Sales by Region (2018-2023) & (K Units)
Table 43. APAC Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Region (2018-2023)
Table 44. APAC Drugs For Herpes Labialis (Oral Herpes) Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Region (2018-2023)
Table 46. APAC Drugs For Herpes Labialis (Oral Herpes) Sales by Type (2018-2023) & (K Units)
Table 47. APAC Drugs For Herpes Labialis (Oral Herpes) Sales by Application (2018-2023) & (K Units)
Table 48. Europe Drugs For Herpes Labialis (Oral Herpes) Sales by Country (2018-2023) & (K Units)
Table 49. Europe Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Country (2018-2023)
Table 50. Europe Drugs For Herpes Labialis (Oral Herpes) Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Country (2018-2023)
Table 52. Europe Drugs For Herpes Labialis (Oral Herpes) Sales by Type (2018-2023) & (K Units)
Table 53. Europe Drugs For Herpes Labialis (Oral Herpes) Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Drugs For Herpes Labialis (Oral Herpes)
Table 61. Key Market Challenges & Risks of Drugs For Herpes Labialis (Oral Herpes)
Table 62. Key Industry Trends of Drugs For Herpes Labialis (Oral Herpes)
Table 63. Drugs For Herpes Labialis (Oral Herpes) Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Drugs For Herpes Labialis (Oral Herpes) Distributors List
Table 66. Drugs For Herpes Labialis (Oral Herpes) Customer List
Table 67. Global Drugs For Herpes Labialis (Oral Herpes) Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Drugs For Herpes Labialis (Oral Herpes) Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Drugs For Herpes Labialis (Oral Herpes) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Drugs For Herpes Labialis (Oral Herpes) Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Drugs For Herpes Labialis (Oral Herpes) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Drugs For Herpes Labialis (Oral Herpes) Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Drugs For Herpes Labialis (Oral Herpes) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Drugs For Herpes Labialis (Oral Herpes) Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Drugs For Herpes Labialis (Oral Herpes) Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. GSK Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 82. GSK Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 83. GSK Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. GSK Main Business
Table 85. GSK Latest Developments
Table 86. Novartis Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 87. Novartis Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 88. Novartis Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. Teva Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 92. Teva Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 93. Teva Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. Teva Main Business
Table 95. Teva Latest Developments
Table 96. Mylan Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 97. Mylan Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 98. Mylan Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Mylan Main Business
Table 100. Mylan Latest Developments
Table 101. Cadila Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 102. Cadila Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 103. Cadila Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. Cadila Main Business
Table 105. Cadila Latest Developments
Table 106. Apotex Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 107. Apotex Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 108. Apotex Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 109. Apotex Main Business
Table 110. Apotex Latest Developments
Table 111. Medivir Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 112. Medivir Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 113. Medivir Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Medivir Main Business
Table 115. Medivir Latest Developments
Table 116. Livzon Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 117. Livzon Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 118. Livzon Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. Livzon Main Business
Table 120. Livzon Latest Developments
Table 121. Luoxin Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 122. Luoxin Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 123. Luoxin Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. Luoxin Main Business
Table 125. Luoxin Latest Developments
Table 126. Med shine Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 127. Med shine Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 128. Med shine Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. Med shine Main Business
Table 130. Med shine Latest Developments
Table 131. Bayer (Campho Phenique) Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 132. Bayer (Campho Phenique) Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 133. Bayer (Campho Phenique) Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 134. Bayer (Campho Phenique) Main Business
Table 135. Bayer (Campho Phenique) Latest Developments
Table 136. Blistex Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 137. Blistex Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 138. Blistex Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 139. Blistex Main Business
Table 140. Blistex Latest Developments
Table 141. Kelun Group Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 142. Kelun Group Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 143. Kelun Group Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 144. Kelun Group Main Business
Table 145. Kelun Group Latest Developments
Table 146. Hikma Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 147. Hikma Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 148. Hikma Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 149. Hikma Main Business
Table 150. Hikma Latest Developments
Table 151. Haiwang Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 152. Haiwang Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 153. Haiwang Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 154. Haiwang Main Business
Table 155. Haiwang Latest Developments
Table 156. Carmex Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 157. Carmex Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 158. Carmex Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 159. Carmex Main Business
Table 160. Carmex Latest Developments
Table 161. Cipher Basic Information, Drugs For Herpes Labialis (Oral Herpes) Manufacturing Base, Sales Area and Its Competitors
Table 162. Cipher Drugs For Herpes Labialis (Oral Herpes) Product Portfolios and Specifications
Table 163. Cipher Drugs For Herpes Labialis (Oral Herpes) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 164. Cipher Main Business
Table 165. Cipher Latest Developments

LIST OF FIGURES

Figure 1. Picture of Drugs For Herpes Labialis (Oral Herpes)
Figure 2. Drugs For Herpes Labialis (Oral Herpes) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs For Herpes Labialis (Oral Herpes) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drugs For Herpes Labialis (Oral Herpes) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Valacyclovir
Figure 10. Product Picture of Aciclovir
Figure 11. Product Picture of Famciclovir
Figure 12. Product Picture of Docosanol
Figure 13. Product Picture of Other
Figure 14. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2022
Figure 15. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2018-2023)
Figure 16. Drugs For Herpes Labialis (Oral Herpes) Consumed in Tablets
Figure 17. Global Drugs For Herpes Labialis (Oral Herpes) Market: Tablets (2018-2023) & (K Units)
Figure 18. Drugs For Herpes Labialis (Oral Herpes) Consumed in Capsules
Figure 19. Global Drugs For Herpes Labialis (Oral Herpes) Market: Capsules (2018-2023) & (K Units)
Figure 20. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Application (2022)
Figure 21. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Application in 2022
Figure 22. Drugs For Herpes Labialis (Oral Herpes) Sales Market by Company in 2022 (K Units)
Figure 23. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2022
Figure 24. Drugs For Herpes Labialis (Oral Herpes) Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Company in 2022
Figure 26. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Drugs For Herpes Labialis (Oral Herpes) Sales 2018-2023 (K Units)
Figure 29. Americas Drugs For Herpes Labialis (Oral Herpes) Revenue 2018-2023 ($ Millions)
Figure 30. APAC Drugs For Herpes Labialis (Oral Herpes) Sales 2018-2023 (K Units)
Figure 31. APAC Drugs For Herpes Labialis (Oral Herpes) Revenue 2018-2023 ($ Millions)
Figure 32. Europe Drugs For Herpes Labialis (Oral Herpes) Sales 2018-2023 (K Units)
Figure 33. Europe Drugs For Herpes Labialis (Oral Herpes) Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Revenue 2018-2023 ($ Millions)
Figure 36. Americas Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Country in 2022
Figure 37. Americas Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Country in 2022
Figure 38. Americas Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Type (2018-2023)
Figure 39. Americas Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Application (2018-2023)
Figure 40. United States Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Region in 2022
Figure 45. APAC Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Regions in 2022
Figure 46. APAC Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Type (2018-2023)
Figure 47. APAC Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Application (2018-2023)
Figure 48. China Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Country in 2022
Figure 56. Europe Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Country in 2022
Figure 57. Europe Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Type (2018-2023)
Figure 58. Europe Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Application (2018-2023)
Figure 59. Germany Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Sales Market Share by Application (2018-2023)
Figure 68. Egypt Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Drugs For Herpes Labialis (Oral Herpes) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Drugs For Herpes Labialis (Oral Herpes) in 2022
Figure 74. Manufacturing Process Analysis of Drugs For Herpes Labialis (Oral Herpes)
Figure 75. Industry Chain Structure of Drugs For Herpes Labialis (Oral Herpes)
Figure 76. Channels of Distribution
Figure 77. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Forecast by Region (2024-2029)
Figure 78. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Drugs For Herpes Labialis (Oral Herpes) Revenue Market Share Forecast by Application (2024-2029)


More Publications